Patients With Cancer May Overly Self-Refer to ED
Adults with cancer may not be using available clinician advice before self-referring to the ED,...
Read MoreJan 5, 2024
Adults with cancer may not be using available clinician advice before self-referring to the ED,...
Read MoreJan 5, 2024
Black patients who are newly diagnosed with colorectal cancer (CRC) receive worse and less-timely...
Read MoreJan 5, 2024
Over time, young adults are moving away from combustible cigarettes to e-cigarettes, according to...
Read MoreJan 5, 2024
1. In patients with mantle-cell lymphoma who responded to induction therapy and autologous stem...
Read MoreJan 4, 2024
The rate of new lung cancer cases has decreased, and survival has improved over the past 5 years,...
Read MoreJan 4, 2024
Researchers described a new familial lung cancer caused by an inherited mutation in EGFR in a...
Read MoreJan 4, 2024
The risk for developing breast cancer after a false-positive mammography result varies with age,...
Read MoreJan 4, 2024
For patients with early-stage breast cancer treated with neoadjuvant chemotherapy (NACT), Black...
Read MoreJan 4, 2024
In a clinical practice guideline published in Practical Radiation Oncology, the American Society...
Read MoreDec 30, 2023
In a study comparing atezolizumab monotherapy with platinum-based chemotherapy in advanced...
Read MoreDec 29, 2023
1. Mirvetuximab soravtansine-gynx (MIRV) significantly improved progression-free survival,...
Read MoreDec 27, 2023
1. In this cross-sectional study, family caregivers of patients with advanced cancer had moderate...
Read MoreDec 26, 2023
1. In patients with mantle-cell lymphoma who responded to induction therapy and autologous stem...
Read MoreDec 26, 2023
1. Progression-free survival was 4.1 months in the combination arm vs 2.2 months in the...
Read MoreDec 19, 2023
1. Mirvetuximab soravtansine-gynx (MIRV), significantly improved progression-free survival,...
Read MoreDec 19, 2023
1. The median overall survival was similar between both groups, 15.2 months in atezolizumab...
Read MoreDec 19, 2023
1. In all patients, there was a 44% reduction in risk of colorectal cancer when using GLP-1RAs as...
Read MoreDec 13, 2023
1. In this cross-sectional study, having carrier status of actionable genes identified by the...
Read MoreDec 12, 2023
1. Median PFS and OS between the tiragolumab and control arms were similar 2. Treatment-related...
Read MoreDec 9, 2023
1. This retrospective cohort study tested ovarian tumors for 113 viruses and found six viruses of...
Read More